Zhang Zheng, Wang Lun, Wei Zhiqiang, E Changyong, Jiang Tao
Department of Hepatobiliary and Pancreatic Surgery, China-Japan Union Hospital, Jilin University, Changchun, China.
Front Surg. 2024 Jan 4;10:1323704. doi: 10.3389/fsurg.2023.1323704. eCollection 2023.
We tried to apply a new surgical method to treat obesity combined with pancreatic pseudocyst and achieved satisfactory results.
We report a case of a severely obese patient with pancreatic pseudocyst who underwent robotic-assisted sleeve gastrectomy, while the pseudocyst was incised and cyst-jejunostomy was performed. The operation was successful, and the patient was discharged on the 8th day after the procedure. There were no complications during the perioperative period. After 12 months of follow-up examinations, the patient's pancreatic pseudocyst disappeared. Additionally, there was a significant decrease in body weight, body mass index, and other indicators. As a result, obesity and related metabolic diseases were completely relieved.
This case summarizes and presents the experience of using robotic bariatric surgery for the treatment of pancreatic pseudocyst. This case report indicates that this surgical procedure is both safe and effective for patients with pancreatic pseudocyst who also have obesity and related metabolic diseases.
我们尝试应用一种新的手术方法来治疗肥胖合并胰腺假性囊肿,并取得了满意的效果。
我们报告一例重度肥胖合并胰腺假性囊肿的患者,该患者接受了机器人辅助袖状胃切除术,同时切开假性囊肿并进行囊肿空肠吻合术。手术成功,患者术后第8天出院。围手术期无并发症。经过12个月的随访检查,患者的胰腺假性囊肿消失。此外,体重、体重指数和其他指标显著下降。因此,肥胖及相关代谢性疾病完全缓解。
本病例总结并展示了使用机器人减肥手术治疗胰腺假性囊肿的经验。本病例报告表明,该手术方法对于合并肥胖及相关代谢性疾病的胰腺假性囊肿患者是安全有效的。